HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Validation of an accelerated high-sensitivity troponin T assay protocol in an Australian cohort with chest pain.

AbstractOBJECTIVES:
To validate an accelerated biomarker strategy using a high-sensitivity cardiac troponin T (hs-cTnT) assay for diagnosing acute myocardial infarction (AMI) in patients presenting to the emergency department with chest pain; and to validate this strategy in combination with the National Heart Foundation of Australia/Cardiac Society of Australia and New Zealand risk stratification model.
DESIGN, SETTING AND PATIENTS:
Single-centre, prospective, observational cohort study of 764 adults presenting to a tertiary hospital with symptoms of possible acute coronary syndrome between November 2008 and February 2011.
MAIN OUTCOME MEASURES:
AMI or cardiac death within 24 hours of presentation (primary), and major adverse cardiac events within 30 days (secondary).
RESULTS:
An elevated hs-cTnT assay result above the 99th percentile at either the 0 h or 2 h time points had sensitivity of 96.4% (95% CI, 87.9%-99.0%), specificity of 82.6% (95% CI, 79.7%-85.2%), negative predictive value of 99.7% (95% CI, 98.8%-99.9%) and positive predictive value of 30.5% (95% CI, 24.2%-37.6%) for diagnosing AMI. Compared with a traditional 6 h cardiac troponin testing strategy, the accelerated strategy led to reclassification of risk in only two patients with adverse cardiac outcomes, with no net effect on appropriate management.
CONCLUSIONS:
In patients presenting with chest pain, an accelerated biomarker strategy using the hs-cTnT assay performed well in the initial diagnosis of AMI. The accelerated strategy was also effective when incorporated into a comprehensive strategy of risk stratification that included clinical and demographic factors. The time saved by this approach could have a major impact on health service delivery.
TRIAL REGISTRATION:
Australian New Zealand Clinical Trials Registry ACTRN12610000053022.
AuthorsWilliam A Parsonage, Jaimi H Greenslade, Christopher J Hammett, Arvin Lamanna, Jillian R Tate, Jacobus P Ungerer, Kevin Chu, Martin Than, Anthony F T Brown, Louise Cullen
JournalThe Medical journal of Australia (Med J Aust) Vol. 200 Issue 3 Pg. 161-5 (Feb 17 2014) ISSN: 1326-5377 [Electronic] Australia
PMID24528432 (Publication Type: Journal Article, Observational Study, Research Support, Non-U.S. Gov't, Validation Study)
Chemical References
  • Troponin T
Topics
  • Acute Coronary Syndrome (diagnosis)
  • Adult
  • Aged
  • Biological Assay (methods)
  • Chest Pain
  • Cohort Studies
  • Female
  • Humans
  • Male
  • Middle Aged
  • Myocardial Infarction (diagnosis)
  • Prospective Studies
  • Risk Assessment
  • Risk Factors
  • Sensitivity and Specificity
  • Troponin T (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: